Literature DB >> 7783074

Fibromyalgia syndrome in children--an outcome study.

D Buskila1, L Neumann, E Hershman, A Gedalia, J Press, S Sukenik.   

Abstract

OBJECTIVE: To assess the outcome of fibromyalgia syndrome (FM) in a 30-month followup study of children with FM.
METHODS: In the original study to assess the prevalence of FM in healthy schoolchildren, we found 21 children with FM and an additional 7 fulfilling the point count criterion only (11 of 18). Fifteen of the 21 and all 7 were recruited for a 2nd assessment in our present study. In all children, a count of 18 tender points (TP) was conducted by thumb palpation. Tenderness of 9 of the TP sites as well as 4 control point sites was further assessed using a Chatillon dolorimeter. All children were questioned concerning the presence of widespread pain or aching. Children were considered to have FM if they met the American College of Rheumatology criteria for diagnosis.
RESULTS: After 30 months, 11 of the 15 children with FM (73%) were no longer fibromyalgic. The mean point count of the 15 children significantly decreased from 12.5 to 4.6 (p < 0.001). The mean tenderness threshold of the 9 tender sites increased from 2.4 to 3.4 kg (p < 0.01), and the mean tenderness threshold of the 4 control sites increased from 4.1 to 5.6 kg (p < 0.05). Of the 7 children initially fulfilling the point count criterion only, none had developed FM. Their mean point count decreased from 11.4 to 3.4 (p = 0.001), and their mean tenderness thresholds increased from 2.7 kg to 3.9 kg (p = 0.001) at tender sites and from 4.3 kg to 6.8 kg (p < 0.001) at control sites.
CONCLUSION: We suggest that the outcome of FM in children is more favorable than in adults. More followup studies are needed to clarify the longterm outcomes of FM in children and adults.

Entities:  

Mesh:

Year:  1995        PMID: 7783074

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

1.  Chronic musculoskeletal and other idiopathic pain syndromes.

Authors:  P N Malleson; H Connell; S M Bennett; C Eccleston
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

2.  Greater trochanteric pain syndrome: epidemiology and associated factors.

Authors:  Neil A Segal; David T Felson; James C Torner; Yanyan Zhu; Jeffrey R Curtis; Jingbo Niu; Michael C Nevitt
Journal:  Arch Phys Med Rehabil       Date:  2007-08       Impact factor: 3.966

Review 3.  Epidemiology of fibromyalgia.

Authors:  Lily Neumann; Dan Buskila
Journal:  Curr Pain Headache Rep       Date:  2003-10

4.  Long-term outcomes of adolescents with juvenile-onset fibromyalgia in early adulthood.

Authors:  Susmita Kashikar-Zuck; Natoshia Cunningham; Soumitri Sil; Maggie H Bromberg; Anne M Lynch-Jordan; Daniel Strotman; James Peugh; Jennie Noll; Tracy V Ting; Scott W Powers; Daniel J Lovell; Lesley M Arnold
Journal:  Pediatrics       Date:  2014-02-24       Impact factor: 7.124

5.  Juvenile fibromyalgia in an adolescent patient with sickle cell disease presenting with chronic pain.

Authors:  Stalin Ramprakash; Daniel Fishman
Journal:  BMJ Case Rep       Date:  2015-10-01

6.  Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome.

Authors:  Susmita Kashikar-Zuck; Irina S Parkins; Tracy V Ting; Emily Verkamp; Anne Lynch-Jordan; Murray Passo; Thomas Brent Graham
Journal:  Rheumatology (Oxford)       Date:  2010-08-05       Impact factor: 7.580

Review 7.  Juvenile Fibromyalgia: Different from the Adult Chronic Pain Syndrome?

Authors:  Susmita Kashikar-Zuck; Christopher King; Tracy V Ting; Lesley M Arnold
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

Review 8.  [Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline].

Authors:  B Zernikow; K Gerhold; G Bürk; W Häuser; C H Hinze; T Hospach; A Illhardt; K Mönkemöller; M Richter; E Schnöbel-Müller; R Häfner
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

9.  [Juvenile fibromyalgia syndrome].

Authors:  H Michels; K Gerhold; R Häfner; W Häuser; A Illhardt; K Mönkemöller; M Richter; L Schuchmann
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

10.  Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome.

Authors:  Susmita Kashikar-Zuck; Irina S Parkins; Thomas Brent Graham; Anne M Lynch; Murray Passo; Megan Johnston; Kenneth N Schikler; Philip J Hashkes; Gerard Banez; Margaret M Richards
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.